9 research outputs found
In vitro biocompatibility of titanium oxide for prosthetic devices nanostructured by low pressure metal-organic chemical vapor deposition
ABSTRACT: Metal-Organic Chemical Vapor Deposition (MOCVD) has recently been proposed to
coat orthopedic and dental prostheses with metal nanostructured oxide films through the
decomposition of oxygenated compounds (single-source precursors) or the reaction of oxygen-free
metal compounds with oxygenating agents. The present study was carried out to assess the in vitro
biocompatibility in terms of cell proliferation and activation, of commercially pure Ti (control material:
TI/MA) coated with nanostructured TiO2 film by MOCVD (Ti/MOCVD) using osteoblast-like cell
cultures (MG-63). Evaluations were performed at 3, 7 and 14 days. Cell proliferation showed a
similar trend for Ti/MA and TiIMOCVD compared to polystyrene; cell number increased with time
from seeding to day 7 (p < 0.005), and then decreased progressively until day 14 (ranging from -14%
to -47%). The ALP level and OC production showed no significant differences between Ti/MOCVD
and Ti/MA at each experimental time. Significantly higher ALP levels were found in Ti/MA at 3 days
and in Ti/MOCVD at 7 and 14 days when compared to the polystyrene group. OC production
decreased over time and the highest values were observed at 3 days, when it was significantly
higher in the Ti/MA than in the polystyrene group (50%, p < 0.05). CICP synthesis was positively
affected by the presence of Ti/MOCVD and was higher in Ti/MOCVD than in the polystyrene group.
No significant differences were found between Ti/MOCVD and Ti/MA in terms of IL-6 and TGF-ß1
synthesis at any experimental time. In conclusion, the current findings demonstrate that the
nanostructured TiO2 coating positively affects the osteoblast-like cell behavior in terms of cell
proliferation and activity, thus confirming its high level of in vitro biocompatibility in accordance with
expectation
CONTROLLING SOFT TISSUE ADHESION ON TITANIUM SURFACES BY NANOGROOVES AND KERATIN NANOFIBRES
Myosin VI and branched actin filaments mediate membrane constriction and fission of melanosomal tubule carriers
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies
Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies.
Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality.
Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42·4% vs 44·2%; absolute difference -1·69 [-9·58 to 6·11] p=0·67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0·0011). ICU mortality was higher in MICs than in HICs (30·5% vs 19·9%; p=0·0004; adjusted effect 16·41% [95% CI 9·52-23·52]; p<0·0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0·80 [95% CI 0·75-0·86]; p<0·0001).
Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status